We provide evidence that the 29-mer region is a core domain modulating PEDF anti-inflammatory signaling in the dry eye milieus and has the potential for development as ophthalmic drops to treat DED, especially in the protection of corneal epithelial integrity. This evidence concerns the gene SERPINF1 and Keratoconjunctivitis sicca.